Journal article
Cost-effectiveness of Lung Cancer Screening in Canada
Abstract
IMPORTANCE: The US National Lung Screening Trial supports screening for lung cancer among smokers using low-dose computed tomographic (LDCT) scans. The cost-effectiveness of screening in a publically funded health care system remains a concern.
OBJECTIVE: To assess the cost-effectiveness of LDCT scan screening for lung cancer within the Canadian health care system.
Authors
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
Journal
JAMA Oncology, Vol. 1, No. 6, pp. 807–813
Publisher
American Medical Association (AMA)
Publication Date
September 1, 2015
DOI
10.1001/jamaoncol.2015.2472
ISSN
2374-2437
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Age FactorsAgedCanadaCost SavingsCost-Benefit AnalysisFemaleHealth Care CostsHumansLung NeoplasmsMaleMass ScreeningMiddle AgedPredictive Value of TestsProtective FactorsQuality-Adjusted Life YearsRadiation DosageRisk AssessmentRisk FactorsSmokingSmoking PreventionTime FactorsTomography, X-Ray Computed